One of Kite Pharma’s CAR-T patients died from cerebral edema, triggering a safety alarm – Endpoints News
Endpoints News |
One of Kite Pharma's CAR–T patients died from cerebral edema, triggering a safety alarm
Endpoints News Kite Pharma revealed today that one of the patients in their late-stage program for the CAR-T drug KTE-C19 died from cerebral edema, the same brain swelling condition that went on to scuttle Juno Therapeutics' lead drug. In a call with analysts for … Kite Pharma Discloses CAR–T Patient Death, Rattling Investors Here's Why Kite Pharma (KITE) Stock Is Plummeting Today Here's What's Dragging Kite Pharma Inc. Down Today |
